Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 01 Feb 2023 for Xeris Biopharma Holdings, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Steven Prestrelski: trading record in brief
Steven Prestrelski is a declared insider at 2 companies; the most frequent names are Xeris Pharmaceuticals Inc and Xeris Biopharma Holdings, Inc. Between 25 June 2018 and 31 January 2023, the trades on record add up to 26 filings.
Every open-market trade on record is a sale: 12 sales worth €802k. The totals exclude 1 filing filed without an amount. Besides market trades, the filings include 6 share grants and 2 option exercises.
The record was last updated on 1 February 2023 with a share grant in Xeris Biopharma Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven Prestrelski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
150,000 shares0Common StockSEC:0001867096-23-000021:0
11,228 shares@ US$0.69100.0% of flowCommon StockSEC:0001867096-22-000025:0
75,000 shares0Common StockSEC:0001867096-22-000006:0
384,780 sharesCommon StockSEC:0000899243-21-039249:0
384,780 sharesCommon StockSEC:0000899243-21-039330:0
5 of 5 declarations
